TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reduction in Symptoms Associated with Alcohol Aftereffects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic complete response in the breast and axillary lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Successful patient rates of ambulatory care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: PrEP Medication Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV Related Knowledge Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HIV Treatment Self-Efficacy survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dose of vasopressor agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Sum of Boxes of the Clinical Dementia Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: pelvic floor muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: pelvic floor muscles endurance of contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Time in Glucose Range (70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of allergic rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of hyper-Lp(a)-aemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse events (AE), serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: freedom from any AF/AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: composite of major safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Radiographic improvement (reduction in pleural effusion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in upper limb functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in power grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery at Day 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall discomfort of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in the number of migraine days per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with > 50% reduction from the baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient's Qualitative Assessment of Treatment Real World version (PQAT-RW)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6MWT Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eligibility rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of participants enrolled in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of long COVID complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skills retention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants who complete therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mechanical power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autism Impact Measure (AIM) Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Organ-preservation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GI microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in GI inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Symptom burden - MSAS
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Symptom burden - MASCC-MAT
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Symptom burden - LFS
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Weight development as assessed by BMI z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SCORing Atopic Dermatitis (SCORAD) Improvement Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Levels of neurocognitive impairment biomarkers in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence, nature, and severity of Treatment Emergent Adverse Events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Dose-limiting toxicity (DLT) incidence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline ambulatory 24-h systolic blood pressure at 12 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline ambulatory 24-h systolic blood pressure at 52 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Success of peripheral venous catheterization at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients who decide to enroll in the trial
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of patients who remain in the trial to completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number and quality of prescribed Pre-Test counseling practices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number and quality of prescribed Post-Test counseling practices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intrapartum infection incidence
Endpoint domain: Adverse events/effects
Primary endpoint: ctDNA variation of the prominent mutant allele
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of new ischemic stroke events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum Neurofilament Light chain (sNfL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Glial Fibrillary Astrocytic Protein (sGFAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: four-fold increase rate of anti-SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Short Form-McGill Pain Questionnaire-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of Fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Fexofenadine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on the ACTION-tool
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Glycated assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of change in assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: antepartum diagnosis rate of PAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 second sit and stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gameplay experience
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CPAP effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain scores at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 8-iso Prostaglandin F2α scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Adenosine Deaminase scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Social isolation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Loneliness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in perceived general health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spectroscopy Reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in Forced Vital Capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in SIB score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in representation of gut bacterial taxa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes of Intervention Use - Distal (Long-Term)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention Engagement Within 3 Hours Following a Decision Point - Proximal (Short-Term)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cross Sample Entropy Between the Heart Rate Sensors of the Horse and Rider
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of planned intervention sessions delivered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants satisfied with the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-grade inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: High contrast, binocular, distance visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in isometric elbow flexion and extension peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in isokinetic elbow flexion and extension peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in cross-sectional area of the elbow flexor and extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in volume of the elbow flexor and extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Voluntary activation of biceps brachii
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Locoregional recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Western Ontario and McMaster University's Osteoarthritis Index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Movement Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time to modified Aldrete score ≥ 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alcohol related risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in risk drinking levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anxiety or anxiety-related symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in psychiatric diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting blood glucose change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in stiffness measured by SWE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microvessel signal grade measured by AP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in thickness measured by high frequency ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interest in RCT enrollment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence, nature and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment discontinuation due to AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes in cognitive functions from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time of request of first analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pneumococcal vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cardiovascular screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Osteoporosis screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean change in step count per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Biochemical measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum amino acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum mineral levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Natural logarithm change in uNTx/uCr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver toxic events
Endpoint domain: Adverse events/effects
Primary endpoint: Renal toxic events
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of Forward Head Posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of self-reported HIV self-tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Positive rate of oral Helicobacter pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in FEV1 AUC 0-6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nelson's Foot Reaction Time Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Severity of Depressive Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in suicidal ideation among adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in interview-rated suicidal ideation among adolescent patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-rated suicidal ideation among adolescent patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in RV/LV ratio
Endpoint domain: Adverse events/effects
Primary endpoint: Volume of distribution of hydromorphone and hydromorphone-3-glucuronide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Structures Assessment of Ultrasound skills (OSAUS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional cerebral blood flow (CBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Engraftment time of 7shRNA modified CD34+ stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Victorian Institute of Sports Assessment - Achilles (VISA-A)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Defense and Veteran's Pain Rating Scale (DVPRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of patients with chronic pain after thoracotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance covered in 6 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor skill performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Conners Continuous Performance Test (CPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of neonatal respiratory disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Functional and structural alteration of microbiotas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Verbal list learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation in everyday life
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Diagnosis of Giardia lamblia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AUClast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent decrease from baseline in integrated gastric acidity for 24-hour interval after dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in sleep cycle
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Children's Social Skills Assessment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Child and Adolescent Social Phobia Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anti-tetanus antibody response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the drug concentration-time curve from day 0 to day 270 (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the drug concentration-time curve from time 0 to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kujala Anterior Knee Pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Knee Documentation Committee Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Grade 3 and 4 Adverse Events related to polatuzumab vedotin
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 and 4 Adverse events related to nivolumab
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Older Adult Participants With 1 or More Unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Older Adult Participants With 1 or More Solicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Fold Increase (GMFI) of RSV-A, RSV-B, hMPV-A, and hMPV-B Serum Neutralizing Antibody Titers in Older Adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cobb angle correction of instrumented curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of SRS-24 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total Immunoglobulin G (IgG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-acetylcholine receptors antibodies (AChR-Ab)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to follow verbal command
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication adherence based on medication level variability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Directly observed medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late Acute Rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pediatric Nausea Assessment Tool (PeNAT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intraoperative quantitative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with Complete Molecular Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence and severity of all treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence and severity of all severe adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Retinopathy of prematurity diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Retinopathy of prematurity grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes